FDA Inspection
Acerta Pharma, LLCAcerta Pharma, LLC – FDA Inspection, Aug 15, 2017
Record Details
This FDA Inspection record concerns Acerta Pharma, LLC, with an inspection on August 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Sandra S. Saniga (Issuing Officer)
View Company Profile
ID · 5675dee6-83a0-4406-8041-78bdb956d41f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022880
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Acerta Pharma, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Acerta Pharma, LLC
- FDA Inspection 1107120 - 2019-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.